EMG
ABMD

ETF Managers Group’s Abiomed Inc ABMD Stock Holding History

ETF Managers Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,068
Closed -$508K – 714
2022
Q3 		$508K Buy
2,068
+80
+4% +$21.6K 0.02% 419
2022
Q2 		$510K Buy
+1,988
New +$536K 0.01% 470
2021
Q2 		– Sell
-2,243
Closed -$695K – 816
2021
Q1 		$695K Buy
2,243
+330
+17% +$106K 0.01% 332
2020
Q4 		$620K Buy
1,913
+168
+10% +$46.5K 0.01% 302
2020
Q3 		$475K Buy
1,745
+86
+5% +$24.8K 0.02% 315
2020
Q2 		$399K Buy
+1,659
New +$333K 0.01% 298
2017
Q3 		– Sell
-342
Closed -$49K – 511
2017
Q2 		$49K Buy
+342
New +$46K ﹤0.01% 413
2016
Q4 		$21K Sell
191
-297
-61% -$34.4K 0.1% 41
2016
Q3 		$62K Buy
+488
New +$58.5K 0.13% 36
2016
Q1 		$25K Buy
+200
New +$16.9K 0.02% 435

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

ETF Managers Group's ABMD Position: Q4 2022 in Review

ETF Managers Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,068 shares — an estimated $508K sold.

ETF Managers Group first reported a position in ABMD in Q1 2016 and held it in 10 quarters. The position peaked at $695K in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • ETF Managers Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • ETF Managers Group sold 2,068 Abiomed Inc shares in Q4 2022, an estimated $508K.
  • ETF Managers Group first reported a position in Abiomed Inc in Q1 2016 and held it in 10 quarters.
  • ETF Managers Group's Abiomed Inc position peaked at $695K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on ETF Managers Group's 13F filing for Q4 2022, filed 23 Mar 2023.